arrow
J

Jean-Pierre Van Geertruyden

University of Antwerp
H指数:41
被引数:5,986

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Genomic profiling of drug resistance markers in Plasmodium falciparum samples from the Democratic Republic of the Congo (2017) and Tanzania (2020–2021)

刚果民主共和国(2017年)和坦桑尼亚(2020–2021年)恶性疟原虫样本中药物抗性标记物的基因组分析

2026-09-010
OAAI
Protocol for a phase 3, randomized, double-blind clinical trial evaluating the safety and immunogenicity of the MVA-BN® vaccine against mpox in children aged 4 to less than 24 months in the Democratic Republic of the Congo: Data to guide future paediatric vaccination strategies

刚果民主共和国针对4至24个月儿童开展的一项评估MVA-BN®疫苗预防猴痘安全性和免疫原性的Ⅲ期、随机、双盲临床试验方案:指导未来儿科疫苗接种策略的数据

Vaccine
IF3.5
2026-06-290
PRE
Plasmodium falciparum Malaria and Arbovirus Co-Exposure in the Boende Health Zone, Northwestern Democratic Republic of the Congo

刚果民主共和国西北部博恩德卫生区的恶性疟原虫疟疾和虫媒病毒共同暴露

2026-05-050
OAAI
Assessing Ebola virus circulation in the Tshuapa province (Democratic Republic of the Congo): A One Health investigation of wildlife and human interactions

评估埃博拉病毒在坦噶尼喀省(刚果民主共和国)的流行:一项关于野生动物与人类交互的一体化健康调查

2025-11-260
PRE
Implementation of the intermittent preventive treatment of malaria in school-aged children (IPTsc) in moderate and high endemic areas in Tanzania: a policy brief

在坦桑尼亚中等和高疟疾流行区对学龄儿童间歇性预防性治疗(IPTsc)的实施:政策简报

2025-11-180
OAAI
Implementation and effectiveness of intermittent preventive treatment in school aged children using dihydroartemisinin-piperaquine to reduce malaria burden: an implementation research of a cluster randomised trial in Tanzania

使用双氢青蒿素哌喹间歇预防性治疗以降低疟疾负担:坦桑尼亚一项整群随机试验的实施研究——实施与有效性

2025-11-070
OAAI
Ad26.ZEBOV, MVA-BN-Filo Ebola virus disease vaccine regimen plus Ad26.ZEBOV booster at 1 year versus 2 years in health-care and front-line workers in the Democratic Republic of the Congo: secondary and exploratory outcomes of an open-label, randomised, phase 2 trial
2024-07-015
PRE
Safety and Immunogenicity of the Heterologous 2-Dose Ad26.ZEBOV, MVA-BN-Filo Vaccine Regimen in Health Care Providers and Frontliners of the Democratic Republic of the Congo

刚果民主共和国医疗保健提供者和前线的异源2剂量Ad26.ZEBOV,mva-bn-filo疫苗方案的安全性和免疫原性

2023-08-242
OAAI